These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22738944)

  • 1. Rate of weight gain and cardiometabolic abnormalities in children and adolescents.
    Calarge CA; Xie D; Fiedorowicz JG; Burns TL; Haynes WG
    J Pediatr; 2012 Dec; 161(6):1010-5. PubMed ID: 22738944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Metabolic side effects of risperidone in early onset schizophrenia].
    Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
    Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiometabolic outcomes in children and adolescents following discontinuation of long-term risperidone treatment.
    Calarge CA; Nicol G; Schlechte JA; Burns TL
    J Child Adolesc Psychopharmacol; 2014 Apr; 24(3):120-9. PubMed ID: 24725198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weight gain and metabolic abnormalities during extended risperidone treatment in children and adolescents.
    Calarge CA; Acion L; Kuperman S; Tansey M; Schlechte JA
    J Child Adolesc Psychopharmacol; 2009 Apr; 19(2):101-9. PubMed ID: 19364288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weight Gain and Metabolic Consequences of Risperidone in Young Children With Autism Spectrum Disorder.
    Scahill L; Jeon S; Boorin SJ; McDougle CJ; Aman MG; Dziura J; McCracken JT; Caprio S; Arnold LE; Nicol G; Deng Y; Challa SA; Vitiello B
    J Am Acad Child Adolesc Psychiatry; 2016 May; 55(5):415-23. PubMed ID: 27126856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron homeostasis during risperidone treatment in children and adolescents.
    Calarge CA; Ziegler EE; Del Castillo N; Aman M; McDougle CJ; Scahill L; McCracken JT; Arnold LE
    J Clin Psychiatry; 2015 Nov; 76(11):1500-5. PubMed ID: 26301448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of antipsychotics on weight gain, weight-related hormones and homocysteine in children and adolescents: a 1-year follow-up study.
    Baeza I; Vigo L; de la Serna E; Calvo-Escalona R; Merchán-Naranjo J; Rodríguez-Latorre P; Arango C; Castro-Fornieles J
    Eur Child Adolesc Psychiatry; 2017 Jan; 26(1):35-46. PubMed ID: 27209421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leptin gene -2548G/A variants predict risperidone-associated weight gain in children and adolescents.
    Calarge CA; Ellingrod VL; Zimmerman B; Acion L; Sivitz WI; Schlechte JA
    Psychiatr Genet; 2009 Dec; 19(6):320-7. PubMed ID: 19873684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weight-Change Trajectories of Pediatric Outpatients Treated with Risperidone or Aripiprazole in a Naturalistic Setting.
    Pozzi M; Pisano S; Marano G; Carnovale C; Bravaccio C; Rafaniello C; Capuano A; Rossi F; Rizzo R; Bernardini R; Nobile M; Molteni M; Clementi E; Biganzoli E; Radice S
    J Child Adolesc Psychopharmacol; 2019 Mar; 29(2):133-140. PubMed ID: 30452281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No Differences in Weight Gain Between Risperidone and Aripiprazole in Children and Adolescents After 12 Months.
    Schoemakers RJ; van Kesteren C; van Rosmalen J; Eussen MLJM; Dieleman HG; Beex-Oosterhuis MM
    J Child Adolesc Psychopharmacol; 2019 Apr; 29(3):192-196. PubMed ID: 30672720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose and lipid metabolism of long-term risperidone monotherapy in patients with schizophrenia.
    Murashita M; Inoue T; Kusumi I; Nakagawa S; Itoh K; Tanaka T; Izumi T; Hosoda H; Kangawa K; Koyama T
    Psychiatry Clin Neurosci; 2007 Feb; 61(1):54-8. PubMed ID: 17239039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body mass index change in autism spectrum disorders: comparison of treatment with risperidone and aripiprazole.
    Wink LK; Early M; Schaefer T; Pottenger A; Horn P; McDougle CJ; Erickson CA
    J Child Adolesc Psychopharmacol; 2014 Mar; 24(2):78-82. PubMed ID: 24564519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risperidone-associated weight gain in children and adolescents: a retrospective chart review.
    Martin A; Landau J; Leebens P; Ulizio K; Cicchetti D; Scahill L; Leckman JF
    J Child Adolesc Psychopharmacol; 2000; 10(4):259-68. PubMed ID: 11191686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second-generation antipsychotic use in children and adolescents: a six-month prospective cohort study in drug-naïve patients.
    Arango C; Giráldez M; Merchán-Naranjo J; Baeza I; Castro-Fornieles J; Alda JA; Martínez-Cantarero C; Moreno C; de Andrés P; Cuerda C; de la Serna E; Correll CU; Fraguas D; Parellada M
    J Am Acad Child Adolesc Psychiatry; 2014 Nov; 53(11):1179-90,1190.e1-4. PubMed ID: 25440308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between serum adiponectin, tumor necrosis factor-alpha, leptin levels and insulin sensitivity in childhood and adolescent obesity: adiponectin is a marker of metabolic syndrome.
    Alikaşifoğlu A; Gönç N; Özön ZA; Sen Y; Kandemir N
    J Clin Res Pediatr Endocrinol; 2009; 1(5):233-9. PubMed ID: 21274300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic effects of second-generation antipsychotics in bipolar youth: comparison with other psychotic and nonpsychotic diagnoses.
    Moreno C; Merchán-Naranjo J; Alvarez M; Baeza I; Alda JA; Martínez-Cantarero C; Parellada M; Sánchez B; de la Serna E; Giráldez M; Arango C
    Bipolar Disord; 2010 Mar; 12(2):172-84. PubMed ID: 20402710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risperidone associated weight, leptin, and anthropometric changes in children and adolescents with psychotic disorders in early treatment.
    Maayan LA; Vakhrusheva J
    Hum Psychopharmacol; 2010 Mar; 25(2):133-8. PubMed ID: 20196182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body mass index increase in preschoolers with heterogeneous psychiatric diagnoses treated with risperidone.
    Avrahami M; Peskin M; Moore T; Drapisz A; Taylor J; Segal-Gavish H; Balan-Moshe L; Shachar I; Levy T; Weizman A; Barzilay R
    J Psychopharmacol; 2021 Sep; 35(9):1134-1140. PubMed ID: 33892604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weight Gain Effects of Second-Generation Antipsychotic Treatment in Autism Spectrum Disorder.
    Yoon Y; Wink LK; Pedapati EV; Horn PS; Erickson CA
    J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):822-827. PubMed ID: 27389348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weight and leptin changes among risperidone-treated youths with autism: 6-month prospective data.
    Martin A; Scahill L; Anderson GM; Aman M; Arnold LE; McCracken J; McDougle CJ; Tierney E; Chuang S; Vitiello B
    Am J Psychiatry; 2004 Jun; 161(6):1125-7. PubMed ID: 15169706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.